Showing results (391-400 of 431) with videos related to
Sort By:
Pageof 44
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2018
Circulating Biomarkers and Resistance to Endocrine Therapy in Metastatic Breast Cancers: Correlative Results from AZD9496 Oral SERD Phase I TrialCostanza Paoletti, Gaia Schiavon, Emily M Dolce, et al.The Lancet. Oncology|December 17, 2009
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trialKathy S Albain, William E Barlow, Steven Shak, et al.Journal of the National Cancer Institute|December 10, 2024
Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trialYara Abdou, William E Barlow, Julie R Gralow, et al.Clinical Breast Cancer|April 1, 2019
Germline Genetic Variants in GATA3 and Breast Cancer Treatment Outcomes in SWOG S8897 Trial and the Pathways StudyVictoria Larsen, William E Barlow, Jun J Yang, et al.NEJM Evidence|July 23, 2024
Clinical and Genomic Risk for Late Breast Cancer Recurrence and SurvivalJoseph A Sparano, Michael Crager, Robert J Gray, et al.Cancer Research|February 28, 2013
HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: implications for efficacy of adjuvant trastuzumabSuthinee Ithimakin, Kathleen C Day, Fayaz Malik, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2019
Validation of the DNA Damage Immune Response Signature in Patients With Triple-Negative Breast Cancer From the SWOG 9313c TrialPriyanka Sharma, William E Barlow, Andrew K Godwin, et al.Archives of Pathology & Laboratory Medicine|June 25, 2009
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancerAntonio C Wolff, M Elizabeth H Hammond, Jared N Schwartz, et al.Nature Genetics|November 5, 2013
Activating ESR1 mutations in hormone-resistant metastatic breast cancerDan R Robinson, Yi-Mi Wu, Pankaj Vats, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2006
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancerAntonio C Wolff, M Elizabeth H Hammond, Jared N Schwartz, et al.Pageof 44